Status and phase
Conditions
Treatments
About
The goal of this study is to identify at least one safe and well tolerated dose of MK1809 that has similar pharmacokinetic qualities as 100 mg losartan.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Part 1:
Part 2:
Exclusion criteria
Part 1:
Part 2
Primary purpose
Allocation
Interventional model
Masking
30 participants in 15 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal